Dorian, P., Kongnakorn, T., Phatak, H., Rublee, D. A., Kuznik, A., Lanitis, T., . . . Lip, G. Y. (2014). Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. Oxford University Press.
استشهاد بنمط شيكاغوDorian, Paul, et al. Cost-effectiveness of Apixaban Vs. Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation. Oxford University Press, 2014.
MLA استشهادDorian, Paul, et al. Cost-effectiveness of Apixaban Vs. Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation. Oxford University Press, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.